Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06TWE
|
|||
| Former ID |
DIB013516
|
|||
| Drug Name |
CLX-0921
|
|||
| Synonyms |
CLX-090502; CLX-090503; CLX-090717; CLX-092402
Click to Show/Hide
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 1 | [1] | |
| Company |
Calyx Therapeutics Inc; Calyx Therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H25NO7S
|
|||
| Canonical SMILES |
COC1=CC(=CC(=C1)C=C(C2=CC=C(C=C2)OC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=O)OC)OC
|
|||
| InChI |
1S/C28H25NO7S/c1-33-22-12-18(13-23(16-22)34-2)14-24(27(31)35-3)19-6-10-21(11-7-19)36-20-8-4-17(5-9-20)15-25-26(30)29-28(32)37-25/h4-14,16,25H,15H2,1-3H3,(H,29,30,32)/b24-14+
|
|||
| InChIKey |
IVAQJHSXBVHUQT-ZVHZXABRSA-N
|
|||
| CAS Number |
CAS 606932-81-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential. Metabolism. 2003 Aug;52(8):1012-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.